Home › Impax Laboratories acquires Tower Holdings and Lineage Therapeutics
 

Keywords :   


Impax Laboratories acquires Tower Holdings and Lineage Therapeutics

2015-03-10 16:40:34| Biotech - Topix.net

Impax Laboratories, Inc. today announced that it has completed its acquisition of Tower Holdings, Inc. , and Lineage Therapeutics Inc. . In connection with the closing of the acquisition, Impax also announced that it is reshaping the operating and reporting structure of its two divisions the Impax generic products division will now be known as "Impax Generics" and the Impax branded products division will now be known as "Impax Specialty Pharma".

Tags: tower holdings laboratories lineage

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Sheboygan Paint Company Appoints New Technical Sales Representative
20.05GK Hair Unveils Summer 2024s Must-Have Hair Trends
20.05Revlon Taps Under Armour\'s Tchernavia Rocker As New Chief People Officer
20.05Canada invests over $9.6M to prevent, prepare for African swine fever
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05Pretty Little Thing warned over 'misleading' ads
20.05Several pork priorities secured in House Farm Bill
20.05BT scraps digital landline switch deadline
More »